More
    Guided Solutions - Connecting Talent With Innovation/div>

    VisCardia secures $40M to advance VisONE heart-failure therapy toward PMA approval

    VisCardia, a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, announced it has secured $40 million in growth financing to advance the company’s path toward Premarket Approval (PMA) for...

    VisCardia secures $40M to advance VisONE heart-failure therapy toward PMA approval

    VisCardia, a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, announced it has secured $40 million in growth financing...

    Xeltis raises €47.5m to advance vascular-access implant aXess toward commercialisation

    Spurred by a positive clinical trial readout recently, Xeltis has raised €47.5m ($55.1m) to advance commercialisation efforts for aXess, a vascular access implant graft...

    Artiria Medical wins CE Mark for SmartGUIDE 014 deflectable guidewire

    Artiria Medical, a Swiss innovator in neurovascular technologies, proudly announces that its SmartGUIDE 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions,...

    Akura Medical closes $53M Series C

    Akura Medical, a Shifamed portfolio company, announced that it completed the first close of its Series C financing, raising $53 million. Los Gatos, California-based Akura...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    JenaValve reports positive Trilogy heart valve data for aortic regurgitation

    JenaValve announced new results from an expanded patient cohort supporting the use of its Trilogy transcatheter heart valve (THV) system. Results from the ALIGN-AR pivotal...

    Vexev robotic ultrasound study meets endpoints

    Vexev and U.S. Renal Care announced successful results from the CANSCAN trial of the VxWave robotic ultrasound imaging system. Sydney, Australia-based Vexev develops the...

    Hyperion completes first-in-human study of Ivy robotic vascular access platform

    Hyperion Surgical announced today that it completed the world’s first robotic-assisted intravenous (IV) catheterisation using its Ivy platform. Ivy integrates advanced imaging, AI and robotic...

    AtriCure treats first patient in the BoxX-NoAF clinical trial

    AtriCure, a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced...

    Innovation

    Regulatory Approvals

    VisCardia secures $40M to advance VisONE heart-failure therapy toward PMA approval

    VisCardia, a medical device company pioneering a novel cardiac-support therapy for patients with heart failure, announced it has secured $40 million in growth financing...

    Xeltis raises €47.5m to advance vascular-access implant aXess toward commercialisation

    Spurred by a positive clinical trial readout recently, Xeltis has raised €47.5m ($55.1m) to advance commercialisation efforts for aXess, a vascular access implant graft...

    Artiria Medical wins CE Mark for SmartGUIDE 014 deflectable guidewire

    Artiria Medical, a Swiss innovator in neurovascular technologies, proudly announces that its SmartGUIDE 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions,...

    Akura Medical closes $53M Series C

    Akura Medical, a Shifamed portfolio company, announced that it completed the first close of its Series C financing, raising $53 million. Los Gatos, California-based Akura...

    M&A

    Archives

    Latest articles